1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: (41) 22-3729366.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Hepatitis delta virus inhibits alpha interferon signaling†
Article first published online: 26 SEP 2008
DOI: 10.1002/hep.22654
Copyright © 2008 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Pugnale, P., Pazienza, V., Guilloux, K. and Negro, F. (2009), Hepatitis delta virus inhibits alpha interferon signaling. Hepatology, 49: 398–406. doi: 10.1002/hep.22654
- †
Potential conflict of interest: Nothing to report.
Publication History
- Issue published online: 28 JAN 2009
- Article first published online: 26 SEP 2008
- Accepted manuscript online: 26 SEP 2008 12:00AM EST
- Manuscript Accepted: 16 SEP 2008
- Manuscript Received: 21 AUG 2008
Funded by
- Essex Chemie AG (Luzern, Switzerland)
References
- 1, , , , . How cells respond to interferons. Annu Rev Biochem 1998; 67: 227–264.
- 2, . Signaling pathways activated by interferons. Exp Hematol 1999; 27: 1583–1592.
- 3, , . Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006; 25: 361–372.
- 4, , . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421.
- 5, Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651–662.
- 6, . Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 2002; 22: 835–845.
- 7. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375–386.
- 8. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778–809, table of contents.
- 9, . Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879–882.
- 10, , . Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 2007; 18: 425–433.
- 11, . JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 2006; 71: 713–721.
- 12, , , , . Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1995; 15: 7050–7058.
- 13, , . Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 1999; 19: 2416–2424.
- 14, , , , , , et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001; 409: 349–354.
- 15, . Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A 2002; 99: 2872–2877.
- 16, . Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 2005; 5: 593–605.
- 17, , , , , , et al. Negative regulation of cytokine signaling by the SOCS proteins. Cold Spring Harb Symp Quant Biol 1999; 64: 397–404.
- 18, . The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 2004; 22: 503–529.
- 19, , , , . Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 2007; 44: 2497–2506.
- 20, , Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2: 675–687.
- 21, , , , , , et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997–1003.
- 22, , , , , . Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 1980; 77: 6124–6128.
- 23, , , , . The hepatitis delta (delta) virus possesses a circular RNA. Nature 1986; 323: 558–560.
- 24, , , , , , et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 1986; 323: 508–514.
- 25, , , , , , et al. Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature 1987; 329: 343–346.
- 26, . A replication cycle for viroids and other small infectious RNA's. Science 1984; 223: 450–455.
- 27, , , , . Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol 2008; 82: 1118–1127.
- 28, , , , , . A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol 1990; 64: 1021–1027.
- 29, , , , , , et al. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol 1988; 62: 2403–2410.
- 30, , . Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 1992; 190: 413–422.
- 31, , , , , , et al. A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol 1988; 62: 594–599.
- 32. The molecular biology of hepatitis delta virus. Annu Rev Biochem 1995; 64: 259–286.
- 33, , . Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol 1989; 63: 1945–1950.
- 34, , . Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol 1990; 64: 5066–5069.
- 35, , , , . The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A 1991; 88: 8490–8494.
- 36, , . Assembly of hepatitis delta virus particles. J Virol 1992; 66: 2310–2315.
- 37, , , , , , et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983; 98: 437–441.
- 38, , , , , , et al. Rapidly progressive HBsAg-positive hepatitis in Italy: the role of hepatitis delta virus infection. J Hepatol 1987; 5: 274–281.
- 39, , , , , , et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000; 46: 420–426.
- 40. Delta hepatitis: an update. J Hepatol 2003; 39(Suppl 1): S212–S219.
- 41, , . Successful treatment of chronic hepatitis D with a short course of peginterferon alfa-2a. Am J Gastroenterol 2005; 100: 1626–1627.Direct Link:
- 42, , , , , , et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. HEPATOLOGY 2006; 44: 728–735.Direct Link:
- 43, , , , , , et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. HEPATOLOGY 2006; 44: 713–720.Direct Link:
- 44, , , , , , et al. A multicenter randomised study comparing the efficacy of pegylated intereron alfa-2A plus adefovir dipivoxil vs. pegylated interferon alfa-2A plus placebo vs. adefovir dipovoxil for the treatment of chronic delta hepatitis: the intervention trial (HID-IT) [Abstract]. HEPATOLOGY 2006; 44(Suppl): 230A.
- 45, , , , . Hepatitis delta virus mutant: effect on RNA editing. J Virol 1995; 69: 7226–7231.
- 46, , . Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008; 374: 487–494.
- 47, , , , , , et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 2005; 79: 12828–12839.
- 48, , . West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 2005; 79: 1343–1350.
- 49, . Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003; 3: 900–911.
- 50, , , . Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996; 84: 443–450.
- 51, , , , , , et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84: 431–442.
- 52, , , , , , et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918–1921.
- 53, . The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001; 12: 143–156.
- 54, , . Viral inhibition of interferon signal transduction. Intervirology 1999; 42: 325–330.
- 55, , . Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000; 81: 2341–2364.
- 56, , , , , , et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998; 187: 675–683.
- 57, , , , . Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 1999; 162: 6107–6113.
- 58, , , , , . Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology 2003; 306: 135–146.
- 59, , , , , , et al. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 2001; 286: 119–124.
- 60, . Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol 2004; 78: 4185–4196.
- 61, , , , , , et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 1999; 18: 5727–5737.
- 62, . SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001; 19: 378–387.Direct Link:
- 63, , , , . The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression. J Biol Chem 1996; 271: 15862–15865.
- 64, , , , , , et al. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 2004; 78: 6282–6286.
- 65, , . Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells. J Virol 1999; 73: 9555–9567.
- 66, , , , . Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J Virol 1997; 71: 6650–6661.
- 67, , , , , , et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002; 76: 5974–5984.